한빛사논문 | BRIC

김승택 님의 논문 목록

김승택Seungtaek Kim

한국파스퇴르연구소

CV File 639 kb

An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation
- Nat. Commun., Apr 20 2024, 15 (1) | https://doi.org/10.1038/s41467-024-47743-1
- 2024-04
- 한빛사논문
Rise in broadly cross-reactive adaptive immunity against human β-coronaviruses in MERS-recovered patients during the COVID-19 pandemic
- Sci. Adv., Mar 2024, 10 (9) | https://doi.org/10.1126/sciadv.adk6425
- 2024-03
- 의약학
- 한빛사논문
Novel SARS-CoV-2 entry inhibitors, 2-anilinoquinazolin-4(3H)-one derivatives, show potency as SARS-CoV-2 antivirals in a human ACE2 transgenic mouse model
- J. Med. Virol., 2023 Jun;95(6):e28863 | https://doi.org/10.1002/jmv.28863
- 2023-06
- 생명과학
- 한빛사논문
Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells
- J. Med. Virol., 2021 Mar;93(3):1403-1408 | https://doi.org/10.1002/jmv.26397
- 2021-03
- 생명과학
- 상위피인용논문
Rapid discovery and classification of inhibitors of coronavirus infection by pseudovirus screen and amplified luminescence proximity homogeneous assay
- Antiviral Res., 2022 Nov 23;105473 | https://doi.org/10.1016/j.antiviral.2022.105473
- 2022-11
- 의약학
- 한빛사논문
Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry
- Angew. Chem.-Int. Edit., First published: 18 January 2022 | https://doi.org/10.1002/anie.202115695
- 2022-01
- 생명과학
- 한빛사논문
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
- Antimicrob. Agents Chemother., 23 June 2020 | https://doi.org/10.1128/AAC.00819-20
- 2020-06
- 생명과학
- 상위피인용논문
Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay
- Proc. Natl. Acad. Sci. USA, July 27, 2021, 118 (30) : e2024302118 | https://doi.org/10.1073/pnas.2024302118
- 2021-07
- 생명과학
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기